Ovoca Bio | OVG - Ordinary Share Capital


Ovoca Bio reported EUR11.06M in Ordinary Share Capital for its fiscal semester ending in June of 2022.





Ordinary Share Capital Change Date
Akebia Therapeutics USD 2K 0 Mar/2025
Alaunos Therapeutics USD 2.21M 2.2M Sep/2025
ALKERMES USD 165.1M 49K Sep/2025
Dianthus Therapeutics USD 42.85M 42.82M Sep/2025
Great Western Mining Corporation EUR 457.75K 100K Jun/2023
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
IQVIA Holdings USD 169.6M 700K Dec/2025
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organon & Co USD 259.98M 18K Sep/2025
Ovoca Bio EUR 11.06M 0 Jun/2022
Revvity USD 113.38M 2.7M Dec/2025
Tectonic Therapeutic USD 14.86M 111.83K Dec/2024
Viatris USD 1.16B 6.55M Sep/2025
Xeris Pharmaceuticals USD 165.53M 165.51M Sep/2025